Tope Adeniyi is a senior clinical embryologist and NIHR clinical fellow at the Department of Reproductive Medicine, Old Saint Mary’s Hospital Manchester and Maternal and Fetal Health research group, University of Manchester.
He attended the University of Leeds where he obtained a Master’s degree in clinical embryology in 2004. Following graduation he has continued to follow his clinical embryology and clinical research interests in ART embryo culture media and oocyte cryopreservation. In 2015, he was awarded the prestigious NIHR Clinical Doctoral Research Fellowship to investigate the impact of ART methods of cryopreservation on oocyte health in IVF and oncology patients.
Nasser Al Asmar Piñar
Nasser Al Asmar Piñar
Nasser Al-Asmar received his Bachelor’s degree in Pharmacy, Graduated in Specialization in Genetic Counselling and Clinical Genomics, and a Master’s degree in Biotechnology of Human Assisted Reproduction at Valencia University, Spain. He has got his PhD in Biomedicine and Biotechnology at Valencia University, Spain. He was Laboratory Manager at Igenomix USA (Miami, FL) from its opening in 2012 until January 2016, when he became Scientific Advisor first in the USA and now for Spain and Latam. He is a member of the permanent board of the Genetics Interest Group of ASEBIR (Association for the Study of the Biology of Reproduction) and Professor at the Master of Biology and Technology of Mammal Reproduction at the University of Murcia (UMU), Spain.
Nasser Al-Asmar has over 15 years of clinical and research laboratory experience, first at IVI-Valencia Clinic (Valencia, Spain) at the Preimplantation Genetic Diagnosis Laboratory, after that at Igenomix (Valencia, Spain) at the Preimplantation Genetic Screening Laboratory and then at Igenomix USA (Miami, FL).
In 2019 Nasser Al-Asmar had lectures in International Conferences in countries such as Argentina, India, Nigeria, Kuwait, Japan, Hong Kong, Spain… about all different topics in Reproductive Genetics. In 2020-21 he had the same experience but virtually, giving lectures in Conferences for Austria, Ukraine, Perú, Brazil, Taiwan, India, Dubai, KSA, Korea, Argentina, Spain…. In this 2022, in person congresses begin again giving lectures in Spain such as in Madrid, Barcelona, Bilbao or Murcia and in other countries such as Argentina, Chile, Brazil and Colombia.
Ernesto Bosch was born in Philadelphia, in 1968. Graduated in 1992, became specialist in Obsterics and Gynecology in 1997. He obtained his Ph.D in 1999, and a Global Executive MBA in 2020. Since 2000 belongs to the Instituto Valenciano de Infertilidad in Valencia where is the current Clinic Director.
Jan Bosteels, MD, PhD is the Head of department of Obstetrics and Gynecology of the Imelda hospital, Bonheiden, Belgium. He is a general gynecologist with special interest in reproductive surgery. He is editor of the Cochrane Gynecology and Fertility Group and active member of the Cochrane Collaboration. He has authored several systematic reviews, including 4 Cochrane systematic reviews. He is scientific collaborator of the department Development and Regeneration, Faculty of medicine KU Leuven and visiting professor department Development and Regeneration at the university of Ghent, Belgium. He has authored 85 peer reviewed publications and given many lectures worldwide mainly on the effectiveness of reproductive surgery for improving reproductive outcomes. The past years he has been involved in designing and conducting RCTs on the effectiveness of vNOTES surgery for benign gynecological disease.
Dr. Nino Guy Cassuto graduated in Pharmacy from Montpellier University and Medicine from Paris University.
He is the head of the Drouot laboratory. Since 1995, he has also led the assisted reproduction units of three hospitals in Paris. His research fields are embryo development and male infertility with a process for sperm selection by Artificial intelligence.
He has published over 30 original articles in international journals; particularly concerning sperm morphology. He continues to pursue his special interests in early embryo development, with a particular emphasis on the role of spermatozoa and their gene expression.
Nino Guy Cassuto has given lectures at International Congress in ESHRE; ASRM; and different countries such as Spain; France; Italia; the UK; Russia; Ukraine; Armenia; Turkey; Israel; Morocco; Tunisia; Algeria; Cameroun; Ivory Coast; Togo; Congo.
He has taught and trained laboratories all over North Africa; Ouest Africa and East Europe.
Núria Correa Mañas is a Data Team lead at R+D department in Eugin Group and PhD student in Artificial Intelligence. ESHRE certified Senior Embryologist with 10 years of experience in the lab.
Christos Coutifaris, M.D., Ph.D. is the Celso Ramon Garcia Professor of Obstetrics and Gynecology in the Division of Reproductive Endocrinology and Infertility at the University of Pennsylvania. He has directed research programs in reproduction under continuous NIH grant support for more than 25 years. He has served on the Division of Reproductive Endocrinology and Infertility of the American Board of Obstetrics and Gynecology, was President of the American Society for Reproductive Medicine and is currently President of the American Gynecological and Obstetrical Society. He is an elected member of the National Academy of Medicine in the United States.
Dr Decherney is the Branch Chief for Reproductive Endocrinology and Infertility and Gynecology at the National Institute of Child Health and Human Development. His special interests include Reproductive Endocrinology, IVF and Reproductive Surgery. He is the past president of ASRM and Society of Reproductive Investigation and member of the National Academy of Medicine.
Georg Griesinger is Professor at Luebeck University in Germany.
He is currently editor for Reproductive Biomedicine Online and editor in-chief at Gynecological Endocrinology (Springer).
He is member of several working groups of the scientific advisory board for the German Medical Association and member of several guideline development groups of the ESHRE.
Michaël Grynberg is an internationally known, board-certified, specialist in Obstetrics & Gynecology, Reproductive Endocrinology and Infertility, Andrology. He is Professor and Director of the Department of Reproductive Medicine & Fertility Preservation in Antoine Béclère University hospital. He has been founding member of the French Society of Fertility Preservation and is currently the president elect. He is also a member of the Reproductive Endocrinology special interest group of the ESHRE and the Head of the Fertility Department within the French College of Obstetrician Gynecologists. He has authored 3 books, 362 scientific papers (54 book chapters, 153 peer-reviewed publications and 134 abstracts). Among his many contributions to the field: a) He pioneered the technique of in vitro maturation of oocytes (IVM) for women with ovarian resistance to FSH; b) Reported the role of ZO-1 in trophoblastic cells differentiation in human placenta; c) Described the Follicular Output RaTe (FORT) as a mean to assess follicular responsiveness to exogenous FSH; d) Reported differential regulation of ovarian anti-Mullerian hormone (AMH) by Estradiol through α- and β- Estrogen receptors; e) Investigated the role of AMH for preventing primordial ovarian follicle loss and fertility alteration following cyclophosphamide administration. His main research interests include: Improving the efficiency of ART, ovarian aging, fertility preservation strategies for cancer and non-medical conditions.
Professor Roger Hart is sub-specialist in reproductive endocrinology and infertility, he is the National Medical Director of City Fertility Clinic, and Professor of Reproductive Medicine, Deputy Head of the Division of Obstetrics and Gynaecology at the University of Western Australia. He has active research interests in the early life origins of male and female reproductive disorder, polycystic ovary syndrome, the longer-term outcomes after IVF treatment, and all aspects of infertility management, and has a particular interest in fertility preservation for patients with a cancer diagnosis and has published over 250 publications in the field of reproductive medicine.
Jose A Horcajadas
Jose A Horcajadas
Jose A. Horcajadas is a Scientist with a large experience in research in Reproductive Medicine.
He is PhD in Molecular Biology and Biochemist and Full Assistant Professor at the University Pablo de Olavide of Seville.
He is also the founder of several companies such as SINAE, Recombine, Fullgenomics, Overture Life or HoMu Health Ventures.
He has focused his investigations mainly in Genetics and he developed several molecular tests to analyze endometrial receptivity in women.
He has published over 80 original articles, books and book chapters, including 58 papers in international journals with an impact factor.
Prof. Milton Ka Hong Leong was brought up in Hong Kong, finished his basic school years, and then went to attend McGill University in Montreal Canada. He did Honours Biochemistry as an undergraduate, and then Medical School. Further postgraduate training in Obstetrics and Gynecology followed, and he obtained his specialists degree in 1974. He then went to London on a McLaughlin Fellowship granted by the Canadian Royal College where he studied under Professors Richard Beard and Stuart Campbell. Returning to Montreal, he joined the McGill University Department as academic staff, and was active in teaching and also headed the High Risk Obstetric Unit.
In 1979 Prof. Leong returned to Hong Kong and engaged in private practice. Seeing a need at that time, he started to concentrate in the study and treatment of Infertility. He set up the IVF Centre at the Hong Kong Sanatorium and Hospital, a private hospital, in joint venture form, and with his partner Dr Clement Leung, they built it up to be one of the most successful IVF clinics in Asia and the world. He “made” and delivered the first IVF baby in Hong Kong in 1985,and in the last 20 years had researched, published, and taught the art and science of infertility and the assisted reproductive techniques.
Prof. Leong is a member of the various reproductive medicine societies, and various international committees. He lecture widely, and still plays an active academic role, and remains to be an Adjunct Professor of Obstetrics and Gynecology in McGill University. His current interest is how to provide the optimal treatment for infertile patients using a patient orientated, more holistic approach.
Kevin Loewke is the Head of Data Science at Alife Health. Before Alife he was Co-Founder of Dana Solutions (which was acquired by Curi Bio) and Co-Founder of Auxogyn (which is now Progyny). He received his PhD from Stanford with a focus on biomedical image analysis and his post-doctoral training at the Stanford Institute for Stem Cell Biology and Regenerative Medicine.
- Sc. in electronic engineering, M.Sc. in mathematics, and Ph.D. in Computer Science.
- Expert in computer vision, artificial intelligence, and biomedical data analysis.
- Professor at the University of Guadalajara and Head of Product Development at IVF 2.0
Ben (Willem) Mol is Professor of Obstetrics and Gynaecology at Monash University. He concentrates on the organisation of multi-centric evaluative research in Obstetrics, Gynaecology and Fertility. His research focuses mainly upon everyday practices. Born and trained in the Netherlands, Ben was instrumental in setting up a nationwide research consortium in women’s health that produced many landmark studies.
Ben came to Australia in 2014 and works as Professor Obstetrics & Gynaecology at Monash University since 2018. Ben is holding continuous NHMRC funding since 2014, including a prestigious investigator grant. He continues to develop extensive relations with Asian universities whilst continuing to collaborate within European networks. Ben has mentored >110 PhD students and has published >1500 papers, many in high impact journals. A publication in Nature acknowledged Ben as one of the most prolific medical scientists. His professional adage is ‘A day without randomisation is a day without progress.’
Belen Moliner, MD, PhD, is an European fellowship in reproductive medicine certified by ESHRE/EBOCG. She completed her specialty with masters in statistics, autoimmune diseases and reproductive medicine. In addition, she studied about genetics, stem cells and artificial intelligence. She has been Spanish coordinator of Imaging in Reproductive Medicine Group. Her clinical expertise and research interests include infertility treatment, 3D ultrasound in reproductive medicine and endometriosis.
Prof Engin Oral, MD is a reproduc6ve endocrinologist and an endometriosis specialist. Upon
comple6on of his residency at Istanbul University Cerrahpasa Medical Faculty he finished his
postdoctoral training at Yale University, New Haven, USA. Now he serves as a clinical professor
at the Department of Obstetrics and Gynaecology at Bezmialem Vakıf University, Istanbul,
He is the former president of the European Endometriosis League and an ac6ve member of the
society since 2016. He founded Endometriosis and Adenomyosis Society, Turkey in 2009 and
also serving ac6vely as an execu6ve board member. He was appointed as World Endometriosis
Society Ambassador in March 2019. He is the editor of book “Endometriosis and Adenomyosis:
Global Perspec6ves Across the Lifespan” by Springer Interna6onal Publishing; 2022. He has 73
peer-reviewed ar6cles in interna6onal academic journals, 33 of which are on endometriosis. His
research is mainly focused on endometriosis, ART and infer6lity.
Dr. Pellicer completed her Doctorate in Medicine in 2020, based on her research on ovarian rejuvenation with autologous stem cells, receiving the recognition of CUM LAUDE. She currently works at IVIRMA Valencia since 2021, as an assisted reproduction specialist, after completing a research fellowship in La Fe hospital. She has participated as a researcher in several clinical research projects, including phase II and phase III clinical trials, has given more than 30 national and international lectures, and has published more than 30 scientific articles and book chapters.
Dr. Sherman Silber, a renowned pioneer in microsurgery and infertility, is considered one of the world’s leading authorities on IVF, mini-IVF, sperm retrieval, ICSI, vasectomy reversal, male infertility, tubal ligation reversal, egg and embryo freezing, ovary transplantation and the reproductive biological clock.
He has operated all over the world, including Egypt, Jordan, Syria, Iran, Behrain, Israel and Qatar.
Sherman J. Silber, M.D., and his team have pioneered most of the “miracle” infertility treatments now accepted around the world for both male and female infertility.
Professor Evelyn Telfer holds a chair in Reproductive Biology at the University of Edinburgh and heads a research group in Ovarian Development within the Institute of Cell Biology and Genes and Development Group (CDBS). Her group has a particular interest in developing in vitro models to support oocyte development from immature stages in domestic species and human. Evelyn’s group has developed a culture system that supports in vitro growth of human and bovine primordial follicles to the Metaphase II stage. They are now using these models to study the potential of female germ line stem cells isolated from adult ovaries in a range of species.
Evelyn has published widely in this area and is a regular invited speaker at International meetings, she has several international collaborations and her research is funded by the Medical Research Council U.K. and The Wellcome Trust. Her group has won several awards at international meetings and in 2019 she received the distinguished scientist award from the Society of Reproduction and Fertility and delivered the Anne McLaren memorial lecture at the U.K. Joint Fertility Societies meeting. Evelyn also has an interest in the Public understanding of science and she contributes to workshops and delivers lectures at science festivals and other public forums. Evelyn was appointed Commander of the Order of the British Empire (CBE) in the Queen’s Birthday Honours 2021 for services to female reproductive biology.
Dr Jim Toner trained under Dr Georgeanna Jones in the Norfolk IVF program in the late 1980s and then joined the faculty there, so he knows our next Giant in the Field well. Dr Toner has had leadership roles in the ASRM and SART over many years, and is now Professor in the Reproductive Medicine at Emory University in Atlanta.
Rita Vassena is the founder and CEO of Fecundis, a company dedicated to the development of innovative treatment for human in fertility. She received a DVM and PhD in biotechnology from the University of Milan, Italy, and an MBA from ESADE business school. After graduate studies in Canada and Italy, she completed her postdoctoral training at the Fels Institute for Cancer Research, Philadelphia. Later, she was a researcher at the Center of Regenerative Medicine in Barcelona – Spanish National Stem Cell Bank, where she focused her studies on the developmental competence of human embryos, as well as studying pluripotency in embryonic and induced stem cells. Up to 2022, Dr.Vassena was the Scientific Director of the EUGIN Group, an international network of centers for the treatment of human infertility, with facilities in Europe, North America and South America. Further, Dr.Vassena is the Co-Director of the international Master in Human Assisted reproductive Technologies of the University Pompeu Fabra. Dr.Vassena has co-authored 110+ research papers in several high ranking journals, and served as an Executive Member of ESHRE until 2019.
Johnny S. Younis, MD, is the director of Reproductive Medicine at the Baruch Padeh Medical Center – Poriya. He is a full professor at the Azrieli Faculty of Medicine in Galilee affiliated with Bar-Ilan University. He is the past Chair of the Obstetrics and Gynecology Circle and the past Chair of the Admission Committee at the Faculty of Medicine. He is the past Chair of the Obstetrics and Gynecology Examination Board, the Scientific Council, Israeli Medical Association. Since October 2018, he is the Vice-Dean for Clinical education at the Azrieli Faculty of Medicine in Galilee. His present interests are low ovarian reserve, ovarian reserve biomarkers, endometriosis, and controlled ovarian stimulation.